The involvement of calmodulin in adrenergic and serotoninergic regulation of vascular contrac tility has been studied. Calmodulin inhibitors trifluoperazine and W 13 suppress vasoconstriction of the rat aorta in response to norepinephrine, serotonin, and serotonin 5HT1A and 5HT2A receptor agonists (8 OH DPAT and DOI, respectively) and do not affect the vasodilatory effect of 5HT1B, 5HT2B, and 5HT4 recep tors. The force of aorta contraction in response to 8 OH DPAT increases after the activation of calcium entry through voltage gated Ca 2+ channels. This effect is not related to nonspecific activation of α 1 adrenoceptors, since it is realized in the presence of prazosin. The inhibitor of calmodulin dependent myosin light chain kinase KN93 decreases the vasoconstrictive response to norepinephrine and serotonin by only 20%. Calm odulin inhibitors slightly decrease aortic constriction in response to endothelin 1, vasopressin, angiotensin II, and KCl. Trifluoperazine does not suppress vasoconstriction induced by the G protein activator AlF 4 -. It is assumed that the target of trifluoperazine and W 13 is calmodulin interacting directly with α 1 adrenocep tors and serotonin (5HT1A and 5HT2A) receptors.